HK1129401A1 - Process for obtaining high efficiency human albumin for use in detoxification therapy - Google Patents

Process for obtaining high efficiency human albumin for use in detoxification therapy

Info

Publication number
HK1129401A1
HK1129401A1 HK09109277.6A HK09109277A HK1129401A1 HK 1129401 A1 HK1129401 A1 HK 1129401A1 HK 09109277 A HK09109277 A HK 09109277A HK 1129401 A1 HK1129401 A1 HK 1129401A1
Authority
HK
Hong Kong
Prior art keywords
human albumin
high efficiency
obtaining high
detoxification therapy
efficiency human
Prior art date
Application number
HK09109277.6A
Other languages
English (en)
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39167937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1129401(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of HK1129401A1 publication Critical patent/HK1129401A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK09109277.6A 2007-11-12 2009-10-07 Process for obtaining high efficiency human albumin for use in detoxification therapy HK1129401A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200702983A ES2294976B1 (es) 2007-11-12 2007-11-12 "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".

Publications (1)

Publication Number Publication Date
HK1129401A1 true HK1129401A1 (en) 2009-11-27

Family

ID=39167937

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09109277.6A HK1129401A1 (en) 2007-11-12 2009-10-07 Process for obtaining high efficiency human albumin for use in detoxification therapy

Country Status (16)

Country Link
US (2) US8088416B2 (pt)
EP (1) EP2072056B1 (pt)
JP (2) JP2009137947A (pt)
CN (1) CN101492493B (pt)
AR (1) AR069220A1 (pt)
AU (1) AU2008243225B2 (pt)
BR (1) BRPI0805167B8 (pt)
CA (1) CA2643508C (pt)
CL (1) CL2008003357A1 (pt)
ES (2) ES2294976B1 (pt)
HK (1) HK1129401A1 (pt)
HU (1) HUE026991T2 (pt)
MX (1) MX2008014273A (pt)
NZ (1) NZ572652A (pt)
PL (1) PL2072056T3 (pt)
RU (1) RU2424822C2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
BR112014000042A2 (pt) * 2011-07-05 2017-02-21 Novozymes Biopharma Dk As composição, meio de cultura celular, uso de uma composição, e, método para cultivar células
WO2013125932A1 (ru) * 2012-02-22 2013-08-29 Даугавпилсский Университет Метод определения структурных и функциональных свойств альбумина плазмы крови
AU2013205138B2 (en) * 2012-08-09 2015-06-25 Grifols, S.A. Caprylate Viral Deactivation
CN103087184B (zh) * 2013-01-14 2014-04-02 山西康宝生物制品股份有限公司 人血白蛋白制品中激肽释放酶原激活剂的控制方法
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
ES2524516B1 (es) * 2014-05-29 2015-03-31 Grifols Worldwide Operations Limited Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido
CN110198952B9 (zh) 2016-08-17 2024-05-28 勃林格殷格翰国际公司 制备含有生物分子的高度浓缩的液体制剂的方法
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5128727A (pt) 1974-09-04 1976-03-11 Canon Kk
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4749783A (en) * 1986-07-11 1988-06-07 Miles Laboratories, Inc. Viral inactivation and purification of active proteins
JP3554796B2 (ja) * 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
FR2672604B1 (fr) 1991-02-07 1995-05-05 Pasteur Merieux Serums Vacc Procede pour isoler de l'albumine humaine a partir du surnageant iv, notamment iv-4, ou de la fraction v de cohn ou d'un surnageant ou fraction analogue.
US5368555A (en) * 1992-12-29 1994-11-29 Hepatix, Inc. Organ support system
AUPM388494A0 (en) * 1994-02-16 1994-03-10 Csl Limited Process for removing endotoxins
US5561115A (en) * 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
ES2103236B1 (es) * 1996-01-30 1998-04-16 Grifols Grupo Sa Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
ES2107390B1 (es) 1996-01-30 1998-07-01 Grupo Grifolls S A Procedimiento para la preparacion de albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
AT403989B (de) * 1996-09-16 1998-07-27 Immuno Ag Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
US6096872A (en) * 1997-10-14 2000-08-01 Ortho Diagnostic Systems, Inc. Viral clearance process
US5919907A (en) * 1997-12-22 1999-07-06 Shanbrom Technologies Llc Preparation and utilization of a novel sterile albumin
DE19831061A1 (de) * 1998-07-10 2000-01-13 Rotkreuzstiftung Zentrallab Herstellung von Proteinpräparationen mit verringertem Aggregatgehalt
ATE249847T1 (de) * 1999-06-15 2003-10-15 Bbi Bioseq Inc Schnelle tieftemperatur-drucksterilisation und impfstoffherstellung
KR101077651B1 (ko) * 2002-11-25 2011-10-27 옥타파르마 아게 프리칼리크레인 제거 혈장 유래 알부민 분획
EP1592439B1 (de) 2003-02-13 2007-05-16 Octapharma AG Verfahren zur herstellung einer albuminlösung
EP1608457A1 (en) * 2003-03-12 2005-12-28 Fresenius Kabi Deutschland GmbH Use of recombinant albumin in dialysis after liver failure
FR2866890B1 (fr) * 2004-02-27 2008-04-04 Lab Francais Du Fractionnement Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
EP1831373A2 (en) * 2004-12-22 2007-09-12 Novozymes A/S Recombinant production of serum albumin
DE102005023155A1 (de) * 2005-05-13 2006-11-16 Albutec Gmbh Albuminlösung
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".

Also Published As

Publication number Publication date
ES2564310T3 (es) 2016-03-21
CA2643508A1 (en) 2009-05-12
AR069220A1 (es) 2010-01-06
MX2008014273A (es) 2009-05-11
RU2008144318A (ru) 2010-05-20
EP2072056A1 (en) 2009-06-24
NZ572652A (en) 2010-03-26
US8088416B2 (en) 2012-01-03
JP2009137947A (ja) 2009-06-25
US20090181102A1 (en) 2009-07-16
PL2072056T3 (pl) 2016-06-30
RU2424822C2 (ru) 2011-07-27
US8231599B2 (en) 2012-07-31
CN101492493B (zh) 2013-05-29
JP2013173767A (ja) 2013-09-05
AU2008243225B2 (en) 2011-09-08
CN101492493A (zh) 2009-07-29
CA2643508C (en) 2013-06-11
US20110137283A1 (en) 2011-06-09
EP2072056B1 (en) 2016-02-24
ES2294976B1 (es) 2008-12-16
BRPI0805167A2 (pt) 2009-07-14
JP5744959B2 (ja) 2015-07-08
BRPI0805167B8 (pt) 2021-05-25
HUE026991T2 (en) 2016-08-29
BRPI0805167B1 (pt) 2019-01-02
CL2008003357A1 (es) 2011-01-07
ES2294976A1 (es) 2008-04-01
AU2008243225A1 (en) 2009-05-28

Similar Documents

Publication Publication Date Title
HK1129401A1 (en) Process for obtaining high efficiency human albumin for use in detoxification therapy
WO2008156868A3 (en) Compositions and methods of treating chronic kidney disease
EP3124064A3 (en) Dialysis system including multi-heater power coordination
EP1982736A4 (en) WATER FOR PREPARING DIALYSAT AND DIALYSAT AND PROCESS FOR PRODUCING DIALYSAT USING SAME AND DIALYST
TWI365079B (en) Dialysate regeneration system for portable human dialysis,and method of generating a toxin trap
GB201104384D0 (en) Steerable element for use in surgery
SE0401504D0 (sv) Wearable peritoneal dialysis system
EP1793878A4 (en) METHOD AND SYSTEM FOR THE PHYSIOLOGICAL CONTROL OF A BLOOD PUMP
WO2009146913A3 (de) Organizer zum lösbaren aufnehmen von komponenten von blutschlauchsätzen und verfahren zum herstellen sowie zum vorbereiten desselben
WO2008093165A3 (en) The use of pgil ohgosaccharyltransferase for o-glycosylating proteins
PL2054104T3 (pl) Urządzenie do pozaustrojowej obróbki krwi i sposób przygotowywania obróbki krwi za pomocą urządzenia do pozaustrojowej obróbki krwi
GB201104369D0 (en) Light treatment cartridge
EP1623731A4 (en) PROCESS FOR PLANNING THE SIMULTANEOUS USE OF PERITONEAL DIALYSIS AND HEMODIALYSIS, AND PLANNING DEVICE FOR THE SIMULTANEOUS APPLICATION OF PERITONEAL DIALYSIS AND HEMODIALYSIS
WO2012058585A3 (en) Treatment of heart failure with natriuretic peptides
EP1809307A4 (en) MEDICAL SOLUTION, PROCESS FOR THEIR MANUFACTURE AND USE
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
MX2009006670A (es) Composicion farmaceutica que usa el aliskiren y el avosentan.
PT1656954E (pt) Soluções terapêuticas de albumina humana com baixa actividade do activador de precalicreína (pka) e processo para a obtenção das mesmas
Podichetty et al. Re: Oleske DM, Lavender SA, Andersson GB, et al. Are back supports plus education more effective than education alone in promoting recovery from low back pain? Results from a randomized clinical trial. Spine 2007; 32: 2050-7
EP1553177A4 (en) METHOD FOR DEVELOPING A PHYSIOLOGICALLY ACTIVE PEPTIDE AND ITS APPLICATIONS
UA84491U (ru) Способ комплексного лечения острого деструктивного панкреатита
HUP0400417A2 (en) Process and device for slimming and recovering with dry gas-bath
RU2007119841A (ru) Способ лечения гипергомоцистеинемии
UA29878U (ru) Способ хирургического лечения больных туберкулезом легких
UA43180U (ru) Способ консервативного и хирургического лечения гиперплазии вилочковой железы у детей

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20201112